| Relatedproducts | R-043-100,RabbitantibodytoChAT(167-188):wholeserum R-1621-100,RabbitantibodytoChAT(167-188):affinitypurified |
| BatchNo. | Seeproductlabel |
| Unitsize | 100µg |
| Sequence | Asyntheticpeptide(C-GLFSSYRLPGHTQDTLVAQKSS)asapartofporcineChATprotein(aa:167-188) |
| OtherNames | CholineO-acetyltransferase;CHOACTase;Cholineacetylase |
| Accession | CLAT_PIG |
| MolecularWeight | 2496Da |
| Purity | 85%orgreater |
| Applications | Controlpeptide.ThispeptidemaybeusedtoblockbindingactivityofantibodytoChAT(#R-043-100and#R-1621-100).Biosensisrecommendsoptimaldilutions/concentrationsshouldbedeterminedbytheenduser. |
| Form | Lyophilised. |
| Reconstitution | Reconstitutewith100µLsterile-filtered,distilledwater. |
| Storage | Storelyophilizedpeptidedryat-20°Cto-80°C.Storereconstitutedpeptideat2-8°Cformaximumof2daystoavoiddegradation.Aliquotthereconstitutedpeptideandstoreat-20°Cto-80°C;avoidrepetitivefreeze-thawcycles. |
| ExpiryDate | 12monthsafterpurchase(lyophilizedpeptide). |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。



